Interestingly, however, the binding of the double and triple mutated Ncr1 fusion proteins to all the cell lines was unchanged or even increased, suggesting that the 3 N-glycosylated residues of Ncr1 play little role in the recognition of the tested tumor cell lines. The gene discussed is NCR1; the disease is neoplasm.